Dissecting the Signaling Mechanisms of Smoothened
剖析 Smoothened 的信号机制
基本信息
- 批准号:8272944
- 负责人:
- 金额:$ 33.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsBasal cell carcinomaBiochemicalBiological ModelsBreastCandidate Disease GeneCellsChildCysteineDevelopmentDissectionDisulfidesDrosophila genusDrosophila melanogasterErinaceidaeEventExtracellular DomainG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGeneticGoalsHealthHeterotrimeric GTP-Binding ProteinsHumanLaboratoriesLeadLigandsLung NeoplasmsMalignant NeoplasmsMalignant neoplasm of brainMapsMediatingMethodsMolecularMolecular ConformationMutationPathway interactionsPatternPhenotypePhysiologicalPlayProstateProteinsRegulationRhabdomyosarcomaRoleSaint Jude Children&aposs Research HospitalScientistSignal TransductionSignal Transduction PathwayTestingTrainingTransducersWorkchemotherapycytotoxicdesignextracellularhedgehog signal transductionhuman SMO proteinimprovedin vivoinsightinterestmanmedulloblastomamembernew therapeutic targetnoveloutcome forecastpressureresearch facilityskillssmoothened signaling pathwaytherapeutic targettool
项目摘要
DESCRIPTION (provided by applicant): The Hedgehog (Hh) signal transduction pathway plays an essential role in patterning fields of cells during development, and is frequently activated in cancer. Inappropriate Hh signaling is causative in basal cell carcinoma, the most common cancer in humans, medulloblastoma, the most common malignant brain tumor in children, and rhabdomyosarcoma, where pathway activation correlates with poor prognosis. Hh has also been implicated in sporadic tumors of the lung, breast and prostate. Consequently, the Hh pathway has emerged as an attractive therapeutic target; specific inhibition of Hh signaling will likely have efficacy against these cancers without triggering the undesirable side effects associated with conventional chemotherapy. To design and employ Hh-specific therapies, a clear understanding of the regulatory mechanisms and signaling components controlling physiological Hh signal transduction is of paramount importance. Accordingly, the goals of this proposal are to dissect mechanistic events governing Hh pathway induction and to identify novel effectors facilitating downstream signaling. We will achieve these goals through molecular and functional analysis of Hh signal transduction using the fruit fly Drosophila melanogaster as our model system. Our studies primarily focus on elucidating the signaling mechanisms and downstream effectors of Smoothened, the critical signal transducer of the Hh pathway. Smoothened is a member of the G-protein coupled receptor (GPCR) superfamily. As such, this study includes three Specific Aims designed to better characterize Smoothened GPCR signaling activity: 1) To characterize the extracellular GPCR structural features that facilitate Hh- regulated Smoothened signaling, 2) To identify GPCR functional domains in Smoothened that govern signaling and 3) To map the G-protein effector network functioning downstream of Smoothened. The proposed studies will enhance our understanding of how the Hh signal is initiated and transduced, and may reveal novel therapeutic targets through identifying "pressure points" on Smoothened and within the Hh cascade.
PUBLIC HEALTH RELEVANCE: The Hedgehog (Hh) signal transduction pathway plays an essential role in patterning fields of cells during development, and is frequently activated in cancer. Inappropriate Hh signaling is causative in basal cell carcinoma, the most common cancer in humans, medulloblastoma, the most common malignant brain tumor in children, and rhabdomyosarcoma, where pathway activation correlates with poor prognosis. Hh has also been implicated in sporadic tumors of the lung, breast and prostate. Consequently, the Hh pathway has emerged as an attractive therapeutic target; specific inhibition of Hh signaling will likely have efficacy against these cancers without triggering the undesirable side effects associated with conventional chemotherapy. To design and employ Hh-specific therapies, a clear understanding of the regulatory mechanisms and signaling components controlling physiological Hh signal transduction is of paramount importance. Accordingly, the goals of this proposal are to dissect mechanistic events governing Hh pathway induction and to identify novel effectors facilitating downstream signaling. We will achieve these goals through molecular and functional analysis of Hh signal transduction using the fruit fly Drosophila melanogaster as our model system. The proposed studies will enhance our understanding of how the Hh signal is initiated and transduced, and may reveal novel therapeutic targets through identifying "pressure points" within the Hh cascade.
描述(由申请人提供):Hedgehog(Hh)信号转导途径在细胞发育过程中的模式化领域中发挥重要作用,并且在癌症中经常被激活。不适当的 Hh 信号传导是基底细胞癌(人类最常见的癌症)、髓母细胞瘤(儿童最常见的恶性脑肿瘤)和横纹肌肉瘤的病因,其中通路激活与不良预后相关。 Hh 还与肺癌、乳腺癌和前列腺的散发性肿瘤有关。因此,Hh 通路已成为一个有吸引力的治疗靶点。 Hh 信号传导的特异性抑制可能对这些癌症有效,而不会引发与传统化疗相关的不良副作用。为了设计和使用 Hh 特异性疗法,清楚地了解控制生理性 Hh 信号转导的调节机制和信号成分至关重要。因此,本提案的目标是剖析控制 Hh 通路诱导的机制事件,并确定促进下游信号传导的新效应器。我们将使用果蝇果蝇作为我们的模型系统,通过 Hh 信号转导的分子和功能分析来实现这些目标。我们的研究主要集中于阐明 Hh 通路的关键信号转导器 Smoothened 的信号传导机制和下游效应器。 Smoothened 是 G 蛋白偶联受体 (GPCR) 超家族的成员。因此,本研究包括三个具体目标,旨在更好地表征 Smoothened GPCR 信号传导活性:1) 表征促进 Hh 调节的 Smoothened 信号传导的细胞外 GPCR 结构特征,2) 识别 Smoothened 中控制信号传导的 GPCR 功能域,3) 绘制在 Smoothened 下游发挥作用的 G 蛋白效应网络。拟议的研究将增强我们对 Hh 信号如何启动和转导的理解,并可能通过识别 Smoothened 上和 Hh 级联内的“压力点”来揭示新的治疗靶点。
公共健康相关性:Hedgehog (Hh) 信号转导通路在细胞发育过程中的模式化领域中发挥着重要作用,并且在癌症中经常被激活。不适当的 Hh 信号传导是基底细胞癌(人类最常见的癌症)、髓母细胞瘤(儿童最常见的恶性脑肿瘤)和横纹肌肉瘤的病因,其中通路激活与不良预后相关。 Hh 还与肺癌、乳腺癌和前列腺的散发性肿瘤有关。因此,Hh 通路已成为一个有吸引力的治疗靶点。 Hh 信号传导的特异性抑制可能对这些癌症有效,而不会引发与传统化疗相关的不良副作用。为了设计和使用 Hh 特异性疗法,清楚地了解控制生理性 Hh 信号转导的调节机制和信号成分至关重要。因此,本提案的目标是剖析控制 Hh 通路诱导的机制事件,并确定促进下游信号传导的新效应器。我们将使用果蝇果蝇作为我们的模型系统,通过 Hh 信号转导的分子和功能分析来实现这些目标。拟议的研究将增强我们对 Hh 信号如何启动和转导的理解,并可能通过识别 Hh 级联内的“压力点”来揭示新的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stacey Kathryn Ogden其他文献
Stacey Kathryn Ogden的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stacey Kathryn Ogden', 18)}}的其他基金
Mechanisms of Sonic Hedgehog Signal Transduction
Sonic Hedgehog 信号传导机制
- 批准号:
10623037 - 财政年份:2017
- 资助金额:
$ 33.69万 - 项目类别:
Dissecting the Signaling Mechanisms of Smoothened
剖析 Smoothened 的信号机制
- 批准号:
8645654 - 财政年份:2012
- 资助金额:
$ 33.69万 - 项目类别:
Dissecting the Signaling Mechanisms of Smoothened
剖析 Smoothened 的信号机制
- 批准号:
8840272 - 财政年份:2012
- 资助金额:
$ 33.69万 - 项目类别:
Dissecting the Signaling Mechanisms of Smoothened
剖析 Smoothened 的信号机制
- 批准号:
8519479 - 财政年份:2012
- 资助金额:
$ 33.69万 - 项目类别:
相似海外基金
Precision oncology to define basal cell carcinoma (BCC) with high-risk histopathological subtypes
精准肿瘤学定义具有高风险组织病理学亚型的基底细胞癌 (BCC)
- 批准号:
485125 - 财政年份:2023
- 资助金额:
$ 33.69万 - 项目类别:
Operating Grants
Analysis of intraoperative videos from basal cell carcinoma removal surgery
基底细胞癌切除手术术中视频分析
- 批准号:
574060-2022 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
University Undergraduate Student Research Awards
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
Applied Research and Development Grants - Level 3
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2021
- 资助金额:
$ 33.69万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10066547 - 财政年份:2020
- 资助金额:
$ 33.69万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2020
- 资助金额:
$ 33.69万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10212968 - 财政年份:2020
- 资助金额:
$ 33.69万 - 项目类别:
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10430040 - 财政年份:2020
- 资助金额:
$ 33.69万 - 项目类别:














{{item.name}}会员




